The primary endpoint was functional immune tolerance, defined as off all immunosuppressive drugs 24 months after ...

Researchers at the University of Pittsburgh have identified a new way of predicting whether a kidney donor and recipient are ...

A recent study led by Paul DeCaen, Ph.D., associate professor of Pharmacology, has identified novel molecular mechanisms by ...

Fifteen of 20 HLA-matched living donor recipients achieved the primary end point of being immunosuppression-free for more than 2 years.

There are several renal syndromes that are unique to patients with cancer, being caused either by the cancer itself or by its treatment. This Review provides nephrologists—who are essential ...

Techcyte is proud to share results from a published pilot study demonstrating the effectiveness of its AI-powered kidney ...